CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men

Jemal, 2009, Cancer statistics, 2009, CA Cancer J Clin, 59, 225, 10.3322/caac.20006 SimG, 2005, Changing demography of prostate cancer in Asia, Eur J Cancer, 41, 834, 10.1016/j.ejca.2004.12.033 Matsuda, 2007, Comparison of time trends in prostate cancer incidence (1973 1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV VIII, Jpn J Clin Oncol, 37, 556, 10.1093/jjco/hym100 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Matsuda, 2009, Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX, Jpn J Clin Oncol, 39, 468, 10.1093/jjco/hyp077 Rodriguez, 2001, Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States, Cancer Epidemiol Biomarkers Prev, 10, 345 Chokkalingam, 2007, Molecular epidemiology of prostate cancer: hormone-related genetic loci, Front Biosci, 12, 3436, 10.2741/2325 Ntais, 2003, Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes, Eur J Endocrinol, 149, 469, 10.1530/eje.0.1490469 Zimmermann, 2001, The machinery of programmed cell death, Pharmacol Ther, 92, 57, 10.1016/S0163-7258(01)00159-0 de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat Rev Cancer, 6, 24, 10.1038/nrc1782 Siegel, 2006, Caspases at the crossroads of immune-cell life and death, Nat Rev Immunol, 6, 308, 10.1038/nri1809 Ho, 2005, Hawkins CJ. Mammalian initiator apoptotic caspases, Febs J, 272, 5436, 10.1111/j.1742-4658.2005.04966.x Cox, 2007, A common coding variant in CASP8 is associated with breast cancer risk, Nat Genet, 39, 352, 10.1038/ng1981 Vecchi, 2009, Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases, Breast Cancer Res Treat, 113, 607, 10.1007/s10549-008-9963-y MacPherson, 2004, Association of a common variant of the CASP8 gene with reduced risk of breast cancer, J Natl Cancer Inst, 96, 1866, 10.1093/jnci/dji001 Enjuanes, 2008, Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia, Cancer Res, 68, 10178, 10.1158/0008-5472.CAN-08-2221 Son, 2006, Polymorphisms in the caspase-8 gene and the risk of lung cancer, Cancer Genet Cytogenet, 169, 121, 10.1016/j.cancergencyto.2006.04.001 Sun, 2007, A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers, Nat Genet, 39, 605, 10.1038/ng2030 Wang, 2009, A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer, Clin Cancer Res, 15, 2567, 10.1158/1078-0432.CCR-08-2829 Frank, 2006, Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant, Carcinogenesis, 27, 606, 10.1093/carcin/bgi248 Lubahn, 2009, Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma, Prostate, 70, 646, 10.1002/pros.21098 Haiman, 2008, A promoter polymorphism in the CASP8 gene is not associated with cancer risk, Nat Genet, 40, 259, 10.1038/ng0308-259 Wang, 2008, A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population, Clin Cancer Res, 14, 3633, 10.1158/1078-0432.CCR-07-5155 Hengartner, 2000, The biochemistry of apoptosis, Nature, 407, 770, 10.1038/35037710 Frank, 2008, The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study, Breast Cancer Res Treat, 111, 139, 10.1007/s10549-007-9752-z Pittman, 2008, CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population, Br J Cancer, 98, 1434, 10.1038/sj.bjc.6604314 Park, 2008, Aetiology of cancer in Asia, Asian Pac J Cancer Prev, 9, 371 Thorgeirsson, 2008, A variant associated with nicotine dependence, lung cancer and peripheral arterial disease, Nature, 452, 638, 10.1038/nature06846 Bondy, 1999, Low-risk drinking guidelines: the scientific evidence, Can J Public Health, 90, 264, 10.1007/BF03404129